HomeRLAY • NASDAQ
add
Relay Therapeutics Inc
Previous close
$7.06
Day range
$6.74 - $7.20
Year range
$5.70 - $13.32
Market cap
899.99M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 10.01M | 4,327.88% |
Operating expense | 86.53M | -4.71% |
Net income | -81.39M | 13.64% |
Net profit margin | -813.30 | 98.05% |
Earnings per share | -0.62 | 20.51% |
EBITDA | -90.80M | 10.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 749.61M | -20.07% |
Total assets | 841.44M | -18.90% |
Total liabilities | 95.68M | -37.93% |
Total equity | 745.76M | — |
Shares outstanding | 132.74M | — |
Price to book | 1.25 | — |
Return on assets | -27.35% | — |
Return on capital | -28.75% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -81.39M | 13.64% |
Cash from operations | -50.32M | 25.04% |
Cash from investing | 10.53M | -86.02% |
Cash from financing | 48.92M | 3,671.94% |
Net change in cash | 9.13M | -3.70% |
Free cash flow | -24.60M | 32.53% |
About
Founded
2015
Website
Employees
309